Medpace Holdings (MEDP) Long-Term Deferred Tax (2016 - 2025)
Medpace Holdings (MEDP) has disclosed Long-Term Deferred Tax for 11 consecutive years, with $37.2 million as the latest value for Q3 2025.
- For the quarter ending Q3 2025, Long-Term Deferred Tax fell 51.5% year-over-year to $37.2 million, compared with a TTM value of $37.2 million through Sep 2025, down 51.5%, and an annual FY2024 reading of $100.4 million, up 34.83% over the prior year.
- Long-Term Deferred Tax was $37.2 million for Q3 2025 at Medpace Holdings, down from $65.8 million in the prior quarter.
- Across five years, Long-Term Deferred Tax topped out at $100.4 million in Q4 2024 and bottomed at $540000.0 in Q2 2021.
- Average Long-Term Deferred Tax over 5 years is $48.4 million, with a median of $49.2 million recorded in 2023.
- The sharpest move saw Long-Term Deferred Tax soared 4796.48% in 2022, then tumbled 51.5% in 2025.
- Year by year, Long-Term Deferred Tax stood at $25.1 million in 2021, then surged by 91.31% to $48.1 million in 2022, then soared by 54.81% to $74.4 million in 2023, then skyrocketed by 34.83% to $100.4 million in 2024, then tumbled by 62.94% to $37.2 million in 2025.
- Business Quant data shows Long-Term Deferred Tax for MEDP at $37.2 million in Q3 2025, $65.8 million in Q2 2025, and $99.7 million in Q1 2025.